Back to feed
GALTGALECTIN THERAPEUTICS INC
CIK 0001133416 · last filing 3d ago · 3 insider transactions
Buy volume
$9.3K
2 buy transactions
Sell volume
$23.7K
1 sell transaction
Net flow
-$14.4K
Net selling
Total flow
$33.0K
3 priced transactions
Disclosure radarcross-source convergence
Divergent3/5 sources
6/100
Recent disclosures · timeline
- Form 1442d ago
Proposed sale of 68,287 sh ($341.4K) · discretionary
- Form 43d ago
Chief Medical Officer · sold $14.4K
Price · GALT
Live chart by TradingViewLive chart via TradingView. Insider trade price and date are from the underlying SEC filing. Not financial advice.
GALT insider flow· last 30 days
Buys Sellsnet -$14.4K
Institutional holders · 13F
Q1 2026 vs Q4 2025 · live SEC data1 fund holds$2.23M reported valueNet accumulating(1 adding · 0 reducing)
| Fund | Shares | Value | % of portfolio | QoQ |
|---|---|---|---|---|
| BlackRock Inc | 799,237 | $2.23M | 0.0% | Add |
Proposed sales · Form 144
selling intent · live SEC data1 notice$341.4K proposed to sell0/1 under a 10b5-1 plan
| Filed | Filer | Shares | Est. value | Approx. sale | Source of shares | Plan |
|---|---|---|---|---|---|---|
| 2d ago | Jamil Khurram Officer | 68,287 | $341.4K | Jun 26, 2026 | Stock Option Exercise | Discretionary |
Recent insider transactions
| Filed | Insider | Transaction | Shares | Price | Value | Signal | Flags | |
|---|---|---|---|---|---|---|---|---|
3d ago Jun 23, 2026 | Jamil Khurram Chief Medical Officer | Buy · M | 7,557 | $0.00 | $0 | Neutral+7 | 10b5-1Deriv | |
3d ago Jun 23, 2026 | Jamil Khurram Chief Medical Officer | Sell · S | 7,557 | $3.14 | $23.7K | Neutral+7 | 10b5-1 | |
3d ago Jun 23, 2026 | Jamil Khurram Chief Medical Officer | Buy · M | 7,557 | $1.23 | $9.3K | Neutral+7 | 10b5-1 |